logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
EMA ScreenerEMA Screener
SMA ScreenerSMA Screener
WMA ScreenerWMA Screener
OHLC ScreenerOHLC Screener
Fibonacci ScreenerFibonacci Screener
VWAP ScreenerVWAP Screener
Pivot Point ScreenerPivot Point Screener
Overlay ScreenerOverlay Screener
Trend Indicator ScreenerTrend Indicator Screener
Volume Based Indicator ScreenerVolume Based Indicator Screener
Overbought/Sold ScreenerOverbought/Sold Screener
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Precious Metals
Gold Price TodayGold Price TodayNew
Silver Price TodaySilver Price TodayNew
Platinum Price TodayPlatinum Price TodayNew
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Indo US Bio-Tech Ltd

Indo US Bio-Tech

Small Cap883 EmployeesIPO 2018
Current Price
100.58
0.66 (0.66%)Updated
NSE :INDOUS
BSE :541304
Valuation vs Sector
P/E Ratio
-vs 34.88
P/B Ratio
-vs 8.76
Div Yield
0.17%vs 1.70%
Today's Range
99.95
100.58
indicator
103.4
52 Week Range
52W Low96.05
52W High206.00
100.58
indicator
Downside4.72%
Upside104.81%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
289.45 Cr
Market Cap
Total market value of company
P/E Ratio
19.51
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
3.07
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
7.42
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
8.64%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
15.40%
ROCE
Return on Capital Employed. >15% is good
Net Margin
11.64%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
36.07%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
21.17%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
5.64%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-24.00%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.19
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
39.16
Book Value
Net asset value per share
Dividend Yield
0.17%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
70.20%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

4 points
  • Promoter holding is consistently high at 70.18-70.2%, indicating strong confidence from the management and a stable ownership structure, which can be reassuring for long-term investors.
  • The company demonstrates good operational efficiency with a Return on Equity (ROE) of 16.90% and Return on Capital Employed (ROCE) of 15.40%, suggesting effective utilization of shareholder funds and capital.

Weaknesses

4 points
  • The stock trades at a high P/E ratio of 55.40, significantly above the sector P/E of 41.32 and many peers, suggesting it might be overvalued compared to its earnings.
  • The latest quarterly profit after tax (PAT) saw a notable decline of -24.00%, which could signal challenges in profitability or increasing operational costs in the short term.

Opportunities

3 points
  • As part of the "Other Agricultural Products" industry within the "Fast Moving Consumer Goods" sector, the company can capitalize on increasing demand for agricultural inputs and processed goods.
  • Given its relatively small market cap of 280 Cr, Indo US Bio-Tech has significant room for market share expansion and diversification into new geographical regions or product lines.

Threats

4 points
  • The "Other Agricultural Products" industry is competitive, with peers like Kaveri Seed Co. and KRBL, posing a threat to market share and pricing power for Indo US Bio-Tech.
  • The agricultural sector is often subject to evolving government policies and regulations, which could impact operations, product approvals, or subsidy structures, affecting profitability.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

No insider trading data available

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4109.57+₹8.99+8.94%
R3106.12+₹5.54+5.51%
R2104.76+₹4.18+4.16%
R1102.67+₹2.09+2.08%
PIVOT101.310.730.73%
CURRENT100.58--
S192.32-₹8.26-8.21%
S295.77-₹4.81-4.78%
S397.86-₹2.72-2.70%
S499.22-₹1.36-1.35%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.13L
(27 May 2026)
-22.5% vs avg
Delivery %
75.0%
(27 May 2026)
+14.9% vs avg
Avg Volume (20D)
0.17L
(29 Apr - 27 May)
20-day average
Avg Delivery %
60.2%
(29 Apr - 27 May)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Godrej Agrovet Ltd
12,413.88 ₹ Cr
Best Profit Growth
Harrisons Malayalam Ltd
206.00 %
Highest Dividend Yield
Godrej Agrovet Ltd
1.70 %

Peer Comparison

Company Name
GODREJAGRO
Godrej Agrovet Ltd
HARRMALAYA
Harrisons Malayalam Ltd
MGEL
Mangalam Global Enterprise Ltd
NATHBIOGEN
Nath Bio-Genes (India) Ltd

About

INDOUS

Indo US Bio-Tech Ltd

Indous Bio-Tech Limited is an Indian company specializing in the agricultural sector, primarily focused on the production, processing, packaging, and marketing of a wide variety of seeds. Their product portfolio encompasses a broad spectrum of agricultural needs, catering to both commercial and vegetable seed requirements.

Their vegetable seed offerings are extensive, including popular choices like tomatoes, okra, and various gourds, alongside root vegetables, leafy greens, and peppers. Beyond vegetables, they also supply cotton seeds and a significant range of oil seeds, such as castor, groundnut, sesame, mustard, and soyabean. The company's product line extends to spices, including cumin and isabgul, pulses (like gram and black gram), and cereals such as wheat and maize.

A key aspect of Indo Us Bio-Tech's business model involves providing agricultural education to local farmers. This commitment to supporting the farming community likely contributes to both the company's success and the broader agricultural development within India. This educational support could involve best practices, modern techniques, or even seed-specific growing advice.

The company's reach extends beyond the domestic market, with a notable export presence in several countries. Their international clientele includes destinations in North America (USA), the Middle East (Kuwait), and various locations in Africa and Asia (Cameroon, Sri Lanka, Mauritius). This demonstrates a capacity for international trade and a successful approach to competing in global agricultural markets. Their export success suggests a high-quality product and efficient operations.

Established in 2004 and headquartered in Ahmedabad, India, Indo Us Bio-Tech Limited has built a substantial presence in the Indian seed industry, leveraging a diverse product portfolio, commitment to farmer education, and successful international expansion.

COMPANY FACTS - INDOUS

Registered Address

309, Shanti Mall, Satadhar Cross Road, Sola Road

Ahmedabad

GUJARAT

IN

Company Details

Group: Food, Beverage & Tobacco

Sector: Consumer Staples

Industry: Food Products

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 883

IPO Date: 11/05/2018

MANAGEMENT - INDOUS

Ms. Rinku Jethva

Chief Financial Officer

Ms. Dimpy Joshi

Compliance Officer, Company Secretary

Mr. Jagdish Ajudia

Managing Director, Executive Director

Mrs. Maltiben Ajudia

Wholetime Director

Ms. Priyanka Ajudia

Executive Director

Mrs. Shilpa Thumar

Additional Independent Director

Mrs. Ritaben Kikani

Non-Executive Independent Director

Mrs. Neha Patel

Non-Executive Independent Director

Investor Questions Answered

Indo US Bio-Tech Ltd (INDOUS) Stock FAQs

Get answers to the most common questions about Indo US Bio-Tech Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Indo US Bio-Tech Ltd (INDOUS) is ₹100.58. Today, the stock has gained by ₹0.66 (0.66%), trading in a range of ₹99.95 to ₹103.4. The stock opened at ₹103.4 with a trading volume of 12,872 shares.
Indo US Bio-Tech Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹289.45 crores, P/E ratio of 19.51, ROE of 8.64%, and ROCE of 15.40%. The dividend yield stands at 0.17%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Indo US Bio-Tech Ltd (INDOUS) is ₹206, while the 52-week low is ₹96.05. Currently trading at ₹100.58, the stock is 4.1% away from its 52-week low and 51.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Indo US Bio-Tech Ltd stock at ₹100.58 depends on multiple factors. The stock is currently trading with a P/E ratio of 19.51 and P/B ratio of N/A. Today's performance shows a gain of 0.66%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Indo US Bio-Tech Ltd offers a dividend yield of 0.17%, which means for every ₹100 invested at the current price of ₹100.58, you can expect to receive approximately ₹0.17 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Indo US Bio-Tech Ltd's key financial metrics include: P/E Ratio: 19.51, P/B Ratio: N/A, ROE: 8.64%, ROCE: 15.40%, Dividend Yield: 0.17%, EPS: ₹7.42, Book Value: ₹39.16, Debt-to-Equity: 0.19, and Current Ratio: N/A. The company's market cap stands at ₹289.45 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Indo US Bio-Tech Ltd stock opened at ₹103.4 and is currently trading at ₹100.58, showing a gain of ₹0.66 (0.66%). The intraday high is ₹103.4 and low is ₹99.95. The trading volume stands at 12,872 shares, indicating moderate market participation today.
Indo US Bio-Tech Ltd has a Price-to-Earnings (P/E) ratio of 19.51, which means investors are willing to pay ₹19.51 for every ₹1 of earnings. With an EPS of ₹7.42, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Indo US Bio-Tech Ltd has a market capitalization of ₹289.45 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹100.58) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Indo US Bio-Tech Ltd has a book value of ₹39.16 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹100.58, which is 156.8% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Indo US Bio-Tech Ltd has a Return on Equity (ROE) of 8.64% and Return on Capital Employed (ROCE) of 15.40%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Indo US Bio-Tech Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Indo US Bio-Tech Ltd has a debt-to-equity ratio of 0.19, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Indo US Bio-Tech Ltd has an Earnings Per Share (EPS) of ₹7.42, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹100.58 and P/E ratio of 19.51, investors are paying 19.51 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Indo US Bio-Tech Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Indo US Bio-Tech Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Indo US Bio-Tech Ltd stock, consider: 1) Fundamental Analysis - Review P/E (19.51), ROE (8.64%), debt-to-equity (0.19), and growth rates. 2) Technical Analysis - Check 52-week range (₹96.05 - ₹206.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹100.58) with book value (₹39.16) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Indo US Bio-Tech Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹100.58 is 906x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Indo US Bio-Tech Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹96.05 - ₹206.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.19 indicates leverage. 4) Liquidity Risk - Based on trading volume of 12,872 shares. 5) Valuation Risk - P/E of 19.51 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Indo US Bio-Tech Ltd operates in the industry with key metrics: P/E ratio of 19.51, ROE of 8.64%, market cap of ₹289.45 crores, and dividend yield of 0.17%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.19), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Indo US Bio-Tech Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹100.58, with a 52-week range of ₹96.05 to ₹206.00. Based on fundamentals like P/E (19.51), ROE (8.64%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Indo US Bio-Tech Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹100.58. 2) Fundamental Deterioration - Declining ROE (currently 8.64%), increasing debt (D/E: 0.19), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Indo US Bio-Tech Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.17%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.